# SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

> **NCT00697372** · PHASE4 · COMPLETED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 150 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Stenosis

## Interventions

- **DEVICE:** Sirolimus eluting stent
- **DEVICE:** Everolimus eluting stent

## Key facts

- **NCT ID:** NCT00697372
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-10
- **Final completion:** 2010-04
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2010-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697372, "SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00697372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*